Yu Du Selected Research

WD repeat containing planar cell polarity effector

3/2020	Expression of Sfrp5/Wnt5a in human epicardial adipose tissue and their relationship with coronary artery disease.
10/2019	High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
1/2019	Sfrp5/Wnt Pathway: A Protective Regulatory System in Atherosclerotic Cardiovascular Disease.
10/2017	Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu Du Research Topics

Disease

37	Neoplasms (Cancer) 11/2022 - 03/2012
11	Hypoxia (Hypoxemia) 01/2022 - 01/2016
11	Cataract (Cataracts) 10/2021 - 07/2017
10	Atherosclerosis 01/2022 - 06/2012
8	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 01/2015
8	Inflammation (Inflammations) 01/2022 - 01/2018
8	Endometriosis 10/2020 - 03/2016
8	Infections 01/2020 - 12/2014
7	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2018
6	Pain (Aches) 07/2021 - 04/2013
6	Coronary Artery Disease (Coronary Atherosclerosis) 03/2020 - 08/2017
5	Carcinoma (Carcinomatosis) 01/2022 - 01/2017
5	Insulin Resistance 01/2022 - 02/2015
5	Ischemia 12/2021 - 09/2012
5	Poisoning 01/2021 - 11/2009
5	Wounds and Injuries (Trauma) 01/2021 - 01/2004
5	Squamous Cell Carcinoma of Head and Neck 05/2015 - 01/2014
4	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2015
4	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2016
4	Carcinogenesis 01/2022 - 01/2018
4	Heart Failure 11/2021 - 07/2014
3	COVID-19 06/2022 - 11/2020
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 07/2014
3	Neuroinflammatory Diseases 09/2021 - 12/2019
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2021 - 10/2018
3	Hypokalemia 01/2021 - 05/2018
3	Obesity 01/2021 - 06/2016
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2020 - 01/2020
3	Pathologic Constriction (Stenosis) 01/2020 - 06/2016
3	ST Elevation Myocardial Infarction 10/2019 - 10/2019
3	Lymphoma (Lymphomas) 01/2019 - 09/2013
3	Hemorrhage 11/2018 - 06/2017
3	Head and Neck Neoplasms (Head and Neck Cancer) 04/2014 - 07/2013
2	Nervous System Diseases (Neurological Disorders) 03/2022 - 01/2022
2	Reperfusion Injury 12/2021 - 10/2019
2	Neuroblastoma 11/2021 - 01/2018
2	Cognitive Dysfunction 09/2021 - 01/2020
2	Lupus Nephritis 02/2021 - 12/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 04/2018
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 01/2021
2	Stomach Neoplasms (Stomach Cancer) 10/2020 - 01/2020
2	Shock 10/2020 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 04/2013

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2012
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2013
14	Pharmaceutical PreparationsIBA 01/2022 - 05/2010
9	Messenger RNA (mRNA)IBA 01/2022 - 01/2015
7	Glucose (Dextrose)FDA LinkGeneric 02/2020 - 02/2015
5	Therapeutic UsesIBA 12/2022 - 09/2019
5	Circular RNAIBA 01/2022 - 10/2020
5	LipidsIBA 05/2021 - 12/2009
5	CholesterolIBA 04/2020 - 12/2009
4	MicroRNAs (MicroRNA)IBA 11/2022 - 01/2015
4	Indicators and Reagents (Reagents)IBA 05/2022 - 01/2017
4	AdipokinesIBA 01/2022 - 06/2016
4	CytokinesIBA 01/2022 - 01/2018
4	Biological ProductsIBA 01/2022 - 02/2003
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2003
4	Estrogens (Estrogen)FDA Link 01/2021 - 01/2017
4	WD repeat containing planar cell polarity effectorIBA 03/2020 - 10/2017
4	Analgesics (Analgesic Drugs)IBA 11/2019 - 04/2013
4	Caspase 3 (Caspase-3)IBA 01/2019 - 01/2004
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 04/2014
3	Interleukin-6 (Interleukin 6)IBA 12/2021 - 11/2020
3	AntioxidantsIBA 09/2021 - 10/2018
3	AcidsIBA 01/2021 - 01/2020
3	CateninsIBA 12/2019 - 04/2013
3	Long Noncoding RNAIBA 08/2019 - 01/2019
3	Insulin (Novolin)FDA Link 01/2018 - 02/2015
3	salicylhydroxamic acid (SHAM)IBA 05/2013 - 09/2012
2	Epidermal Growth Factor (EGF)IBA 01/2022 - 04/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2021
2	Proteolysis Targeting ChimeraIBA 01/2022 - 01/2022
2	Antiviral Agents (Antivirals)IBA 12/2021 - 07/2020
2	Peroxynitrous Acid (Peroxynitrite)IBA 12/2021 - 01/2020
2	vanadium pentoxideIBA 11/2021 - 10/2013
2	AntigensIBA 08/2021 - 01/2011
2	thiamine triphosphorate (TTP)IBA 07/2021 - 01/2018
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 10/2020
2	arsenic disulfide (realgar)IBA 01/2021 - 01/2021
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2021 - 01/2020
2	Crystallins (Crystallin)IBA 01/2021 - 01/2018
2	Choline (Choline Chloride)IBA 01/2021 - 01/2021
2	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 09/2018
2	Phosphotransferases (Kinase)IBA 10/2020 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2020 - 12/2014
2	EnzymesIBA 05/2020 - 11/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 11/2018
2	HexokinaseIBA 01/2020 - 11/2018
2	Phenobarbital (Luminal)FDA Link 01/2020 - 04/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 10/2017

Therapy/Procedure

21	Therapeutics 04/2022 - 12/2012
4	Radiotherapy 01/2021 - 09/2013
4	Slit Lamp 01/2020 - 06/2017
4	Percutaneous Coronary Intervention 10/2019 - 04/2018
3	Intraocular Lenses (Intraocular Lens) 01/2020 - 10/2019
2	Drug Therapy (Chemotherapy) 01/2021 - 09/2013
2	Immunotherapy 01/2021 - 01/2019
2	Diskectomy (Discectomy) 01/2020 - 12/2019